Retention of clinical biosamples / blank matrices [Regulatives / Guidelines]

posted by Ohlbe – France, 2019-04-24 09:54  – Posting: # 20219
Views: 296

Hi John,

» Do you know why some sponsors want to have their samples kept until application approved?

"Because we've always done it", I guess...

» From EMA or FDA, is there a requirement mentioned in any of the guidances?

EMA: no. FDA: not that I know of.

» We are doing this (store samples) as well and I wonder why we need to if the age of the samples exceeds the long term stability date.

I agree with ElMaestro: some sponsors just want to be on the safe side and only repeat the bioanalytical part rather than the whole study if the lab messed up somewhere. There was a time also when guidelines or requirements were not as clear as they can be now and an Agency would unexpectedly ask for the metabolite in addition to the parent, or similar stuff.

Regards
Ohlbe

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,514 posts in 4,141 threads, 1,336 registered users;
online 10 (0 registered, 10 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 08:45 UTC

I have not failed 700 times. I have not failed once.
I have succeeded in proving
that those 700 ways will not work.    Thomas Alva Edison

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5